Indian benchmarks may open higher; foreign flows, US fiscal woes seen capping gains

US-INDIA-STOCKS:Indian benchmarks may open higher; foreign flows, US fiscal woes seen capping gains

Reuters
Published23 May 2025, 08:19 AM IST
Indian benchmarks may open higher; foreign flows, US fiscal woes seen capping gains
Indian benchmarks may open higher; foreign flows, US fiscal woes seen capping gains

(Reuters) -India's benchmark indexes are likely to open higher on Friday, after logging a decline of 1.65% so far this week, although lingering concerns over foreign inflows and the United States' worsening fiscal health could limit gains.

Gift Nifty futures were trading at 24,692.5 as of 7:59 a.m. IST, indicating that the Nifty 50 will open above its previous close of 24,609.7.

Foreign portfolio investors (FPIs) sold Indian shares worth 50.45 billion rupees ($586.8 million) on Thursday, as per provisional data, the third such session of selling in four days.

Thirty-year U.S. bond yields reached their highest level in 19 months before easing on Thursday, after the U.S. House of Representatives passed President Donald Trump's tax bill, which is expected to add about $3.8 trillion to the federal government's debt pile over the next decade.

Concerns over mounting debt and Moody's downgrade of the U.S. credit rating last week have weighed on stocks globally in the last few sessions.

Rising Treasury yields tend to make bonds more attractive to foreign investors, driving out capital from stocks in emerging markets such as India.

Asian markets were cautious on the day, with MSCI Asia ex Japan up 0.1%, after a 0.9% drop in the previous session. [MKTS/GLOB]

The short-term trend in India remains weak and any rise towards the 24,800 level on Nifty could attract selling pressure, said Rupak De, senior technical analyst at LKP Securities.

STOCKS TO WATCH

** Fashion retailer Trent and state-owned defence firm Bharat Electronics to replace IndusInd Bank and Nestle India in BSE Sensex from June 23

** ITC posts higher quarterly profit on the back of strength in its mainstay cigarettes business and resilient rural demand

** Sun Pharmaceutical Industries reports bigger adjusted quarterly profit, driven by strong domestic demand for its drugs to treat rare diseases

(Reporting by Vivek Kumar M; Editing by Sonia Cheema)

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Business NewsMarketsStock MarketsIndian benchmarks may open higher; foreign flows, US fiscal woes seen capping gains
MoreLess